Literature DB >> 19427501

Current approaches to renovascular hypertension.

Stephen C Textor1.   

Abstract

This article examines the status regarding prevalence, mechanisms, clinical manifestations and management of renovascular hypertension at this point in time. It should be viewed as a work in progress. As with most complex conditions, clinicians must integrate the results of published literature studies while considering each patient's specific features and comorbid disease risks. Beyond identifying renovascular disease as a cause of secondary hypertension, one must manage renal artery stenosis (RAS) itself as an atherosclerotic vascular complication. This disease warrants follow-up regarding progression and potential for ischemic tissue injury. These elements often determine the role and timing for revascularization. In this respect, atherosclerotic renal artery stenosis is analogous to progressive carotid or aortic aneurysmal disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427501      PMCID: PMC2752469          DOI: 10.1016/j.mcna.2009.02.012

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  40 in total

1.  Cardiologists performing peripheral angioplasties: impact on utilization.

Authors:  D A Axelrod; A M Fendrick; J D Birkmeyer; D E Wennberg; A E Siewers
Journal:  Eff Clin Pract       Date:  2001 Sep-Oct

2.  Essential role of AT1A receptor in the development of 2K1C hypertension.

Authors:  Ludek Cervenka; Vladislav Horácek; Ivana Vanecková; Jaroslav A Hubácek; Michael I Oliverio; Thomas M Coffman; L Gabriel Navar
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

3.  "Apparent" heart failure: a syndrome caused by renal artery stenoses.

Authors:  C G Missouris; A M Belli; G A MacGregor
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

4.  Resistant hypertension: comparing hemodynamic management to specialist care.

Authors:  Sandra J Taler; Stephen C Textor; Jo Ellen Augustine
Journal:  Hypertension       Date:  2002-05       Impact factor: 10.190

5.  Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure.

Authors:  Bruce H Gray; Jeffrey W Olin; Mary Beth Childs; Timothy M Sullivan; J Michael Bacharach
Journal:  Vasc Med       Date:  2002       Impact factor: 3.239

6.  Angiotensin inhibition in renovascular disease: a population-based cohort study.

Authors:  Daniel G Hackam; Minh L Duong-Hua; Muhammad Mamdani; Ping Li; Sheldon W Tobe; J David Spence; Amit X Garg
Journal:  Am Heart J       Date:  2008-07-21       Impact factor: 4.749

7.  Prediction of clinical response after renal angioplasty: respective value of renal Doppler sonography and scintigraphy.

Authors:  Gilles Soulez; Eric Therasse; Salah Dine Qanadli; Daniel Froment; Michel Léveillé; Viviane Nicolet; Sophie Turpin; Marie-France Giroux; Marie Claude Guertin; Vincent L Oliva
Journal:  AJR Am J Roentgenol       Date:  2003-10       Impact factor: 3.959

8.  Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis.

Authors:  Alejandro R Chade; Martin Rodriguez-Porcel; Joseph P Grande; Xiangyang Zhu; Vincenzo Sica; Claudio Napoli; Tatsuya Sawamura; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-05-15       Impact factor: 8.311

9.  Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study.

Authors:  Francesco Scolari; Pietro Ravani; Alessandra Pola; Simona Guerini; Roberto Zubani; Ezio Movilli; Silvana Savoldi; Fabio Malberti; Rosario Maiorca
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

10.  Prevalence of renovascular disease in the elderly: a population-based study.

Authors:  Kimberley J Hansen; Matthew S Edwards; Timothy E Craven; Gregory S Cherr; Sharon A Jackson; Richard G Appel; Gregory L Burke; Richard H Dean
Journal:  J Vasc Surg       Date:  2002-09       Impact factor: 4.268

View more
  6 in total

1.  In vivo bioluminescence imaging reveals redox-regulated activator protein-1 activation in paraventricular nucleus of mice with renovascular hypertension.

Authors:  Melissa A Burmeister; Colin N Young; Valdir A Braga; Scott D Butler; Ram V Sharma; Robin L Davisson
Journal:  Hypertension       Date:  2010-12-20       Impact factor: 10.190

2.  Non-invasive assessment of cardiac function in a mouse model of renovascular hypertension.

Authors:  Federico Franchi; Bruce E Knudsen; Elise Oehler; Stephen C Textor; Lilach O Lerman; Joseph P Grande; Martin Rodriguez-Porcel
Journal:  Hypertens Res       Date:  2013-05-16       Impact factor: 3.872

3.  Cardiac function in renovascular hypertensive patients with and without renal dysfunction.

Authors:  Kirandeep K Khangura; Alfonso Eirin; Garvan C Kane; Sanjay Misra; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  Am J Hypertens       Date:  2013-10-25       Impact factor: 2.689

4.  Bilateral renal artery stenosis in a patient with chronic myeloid leukemia treated with nilotinib.

Authors:  Tilde Kristensen; Else Randers; Jesper Stentoft
Journal:  Leuk Res Rep       Date:  2012-11-10

5.  Orthostatic hypertension: From pathophysiology to clinical applications and therapeutic considerations.

Authors:  Nikolaos Magkas; Costas Tsioufis; Costas Thomopoulos; Polychronis Dilaveris; Georgios Georgiopoulos; Michael Doumas; Dimitris Papadopoulos; Dimitrios Tousoulis
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-02-06       Impact factor: 3.738

6.  Renovascular Compression by the Diaphragmatic Crus: A Case Report.

Authors:  Ali Al-Smair; Osama Saadeh; Ahmad Saadeh; Ahmad Al-Ali
Journal:  Cureus       Date:  2022-04-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.